780810-20-0

Questions And Answer

• Application

  Cefepime hydrochloride is a fourth-generation injectable cephalosporin developed by Bristol-Myers Squibb. Since its initial market launch in Sweden in 1993, it has been used to treat various bacterial infections. Cefepime has a broad antibacterial spectrum, maintaining good antibacterial activity against Gram-negative bacteria while also exhibiting strong anti-staphylococcal activity. It possesses strong antibacterial properties, high stability against β-lactamases, and good tolerability, making it a promising antibiotic.;

Supplier

Related Products